CASSEY CUEVAS: Open Payments
NPI 1659061646 · ST AUGUSTINE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 16 payments from 8 companies in 2025. Trend: 2023 $932 · 2024 $371 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $100 |
| Alkermes, Inc. | 3 | $65 |
| Neurocrine BioSciences, Inc. | 2 | $60 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Janssen Pharmaceuticals, Inc | 1 | $32 |
| Janssen Biotech, Inc. | 1 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
Products named: CAPLYTA, ARISTADA, INGREZZA, INVEGA SUSTENNA, COBENFY, AUSTEDO XR, FANAPT, UZEDY.
Industry payments across FL — which companies pay providers there.
